IRIS Accounts Production v24.1.4.33 13878327 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh138783272022-12-31138783272023-12-31138783272023-01-012023-12-31138783272022-01-27138783272022-01-282022-12-31138783272022-12-3113878327ns15:EnglandWales2023-01-012023-12-3113878327ns14:PoundSterling2023-01-012023-12-3113878327ns10:Director12023-01-012023-12-3113878327ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3113878327ns10:SmallEntities2023-01-012023-12-3113878327ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3113878327ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3113878327ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3113878327ns10:FullAccounts2023-01-012023-12-3113878327ns10:Director22023-01-012023-12-3113878327ns10:Director32023-01-012023-12-3113878327ns10:Director42023-01-012023-12-3113878327ns10:CompanySecretary12023-01-012023-12-3113878327ns10:RegisteredOffice2023-01-012023-12-3113878327ns5:CurrentFinancialInstruments2023-12-3113878327ns5:CurrentFinancialInstruments2022-12-3113878327ns5:Non-currentFinancialInstruments2023-12-3113878327ns5:Non-currentFinancialInstruments2022-12-3113878327ns5:ShareCapital2023-12-3113878327ns5:ShareCapital2022-12-3113878327ns5:RetainedEarningsAccumulatedLosses2023-12-3113878327ns5:RetainedEarningsAccumulatedLosses2022-12-3113878327ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3113878327ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-31
REGISTERED NUMBER: 13878327 (England and Wales)


















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

RENEWVAX LIMITED

RENEWVAX LIMITED (REGISTERED NUMBER: 13878327)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


RENEWVAX LIMITED

COMPANY INFORMATION
for the Year Ended 31 December 2023







DIRECTORS: A Kadioglu
Dr N D Murray
Ms M O'Brien
Ms E Nolan





SECRETARY: R Bickerstaff





REGISTERED OFFICE: C/o Fairhurst Accountants
Douglas Bank House
Wigan Lane
Wigan
WN1 2TB





REGISTERED NUMBER: 13878327 (England and Wales)





ACCOUNTANTS: Fairhurst
Chartered Accountants
Douglas Bank House
Wigan Lane
Wigan
Lancashire
WN1 2TB

RENEWVAX LIMITED (REGISTERED NUMBER: 13878327)

BALANCE SHEET
31 December 2023

2023 2022
Notes £    £   
CURRENT ASSETS
Debtors 4 43,420 89,374
Cash at bank and in hand 39,350 56,658
82,770 146,032
CREDITORS
Amounts falling due within one year 5 41,355 17,535
NET CURRENT ASSETS 41,415 128,497
TOTAL ASSETS LESS CURRENT
LIABILITIES

41,415

128,497

CREDITORS
Amounts falling due after more than one
year

6

390,000

150,000
NET LIABILITIES (348,585 ) (21,503 )

CAPITAL AND RESERVES
Called up share capital 50 50
Retained earnings (348,635 ) (21,553 )
(348,585 ) (21,503 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 December 2024 and were signed on its behalf by:




Dr N D Murray - Director


RENEWVAX LIMITED (REGISTERED NUMBER: 13878327)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Renewvax Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Financial instruments
The company only holds basic financial instruments, as defined under Section 11 of FRS 102.

Trade and other debtors are initially recognised at the transaction price and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases, the receivables are stated at cost less impairment losses for bad and doubtful debts.

Short term financial liabilities, including trade and other creditors, overdrafts and related party loans, are measured at transaction price. Financial liabilities that have no stated interest rate and are payable within one year shall be measured at the undiscounted amount due, those payable after one year should be measured at amortised cost, using the effective interest rate method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

RENEWVAX LIMITED (REGISTERED NUMBER: 13878327)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2023

2. ACCOUNTING POLICIES - continued

Government grants
Government grants are not recognised until there is reasonable assurance that the associated conditions will be met and that the grant will be received.

Government grants are recognised as Other operating income on a systematic basis over the periods in which the associated expenses are recognised. Grants that are receivable as compensation for expenses or losses previously incurred or for the purpose of giving immediate financial support with no future related costs are recognised in the period in which they become receivable.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2022 - 6 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other debtors 43,420 89,374

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 20,350 12,250
Taxation and social security 13,846 2,414
Other creditors 7,159 2,871
41,355 17,535

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Other creditors 390,000 150,000

7. RELATED PARTY DISCLOSURES

During the year the company was charged expenses amounting to £68,000 (2022: £72,000) by certain directors and their spouse.

At the year end £Nil (2022: £10,000) of the expenses remained outstanding.